These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 19217790

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dipeptidyl peptidase-IV inhibitors: a major new class of oral antidiabetic drug.
    Idris I, Donnelly R.
    Diabetes Obes Metab; 2007 Mar; 9(2):153-65. PubMed ID: 17300591
    [Abstract] [Full Text] [Related]

  • 6. Dipeptidyl peptidase IV inhibitors and the incretin system in type 2 diabetes mellitus.
    Langley AK, Suffoletta TJ, Jennings HR.
    Pharmacotherapy; 2007 Aug; 27(8):1163-80. PubMed ID: 17655515
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?
    Halimi S.
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S91-5. PubMed ID: 18640591
    [Abstract] [Full Text] [Related]

  • 10. Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice.
    Moritoh Y, Takeuchi K, Asakawa T, Kataoka O, Odaka H.
    Eur J Pharmacol; 2008 Jul 07; 588(2-3):325-32. PubMed ID: 18499100
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: focus on sitagliptin.
    Herman GA, Stein PP, Thornberry NA, Wagner JA.
    Clin Pharmacol Ther; 2007 May 07; 81(5):761-7. PubMed ID: 17392725
    [Abstract] [Full Text] [Related]

  • 13. Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
    Neumiller JJ, Wood L, Campbell RK.
    Pharmacotherapy; 2010 May 07; 30(5):463-84. PubMed ID: 20411998
    [Abstract] [Full Text] [Related]

  • 14. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.
    Neumiller JJ.
    J Am Pharm Assoc (2003); 2009 May 07; 49 Suppl 1():S16-29. PubMed ID: 19801361
    [Abstract] [Full Text] [Related]

  • 15. DPP-4 inhibitors and their potential role in the management of type 2 diabetes.
    Barnett A.
    Int J Clin Pract; 2006 Nov 07; 60(11):1454-70. PubMed ID: 17073841
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ, Stevens C, Zhou Y, Yi B, Laethem M, De Smet M, Snyder K, Hilliard D, Tanaka W, Zeng W, Tanen M, Wang AQ, Chen L, Winchell G, Davies MJ, Ramael S, Wagner JA, Herman GA.
    Clin Ther; 2006 Jan 07; 28(1):55-72. PubMed ID: 16490580
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.
    Green BD, Gault VA, O'Harte FP, Flatt PR.
    Diabetes Obes Metab; 2005 Sep 07; 7(5):595-604. PubMed ID: 16050953
    [Abstract] [Full Text] [Related]

  • 19. Incretin mimetics and dipeptidyl peptidase-IV inhibitors: potential new therapies for type 2 diabetes mellitus.
    Triplitt C, Wright A, Chiquette E.
    Pharmacotherapy; 2006 Mar 07; 26(3):360-74. PubMed ID: 16503716
    [Abstract] [Full Text] [Related]

  • 20. The role of vildagliptin in the management of type 2 diabetes mellitus.
    Kleppinger EL, Helms K.
    Ann Pharmacother; 2007 May 07; 41(5):824-32. PubMed ID: 17456545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.